Picture of ENvue Medical logo

FEED — ENvue Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Nanovibronix Announces Encouraging Interim Results In Real World Patient Study Of Uroshield

Dec 7 (Reuters) - Nanovibronix Inc  NAOV.O :
    * NANOVIBRONIX ANNOUNCES ENCOURAGING INTERIM RESULTS IN REAL
WORLD
PATIENT STUDY OF UROSHIELD
    * NANOVIBRONIX INC- FULL RESULTS OF STUDY ARE EXPECTED TO BE
PUBLISHED IN Q2 OF 2022
    * NANOVIBRONIX - URINE ANALYSIS IS DEMONSTRATING APPROXIMATE
1 LOG
REDUCTION IN BACTERIAL NUMBERS IN MOST PATIENTS, A STATISTICALLY
SIGNIFICANT OUTCOME

Source text for Eikon:  ID:nGNX3YyRvS 
Further company coverage:  NAOV.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ENvue Medical

See all news